We hypothesized that enhanced CXCR4 gene expression in CRC could be the result of epigenetic modifications, either through demethylation of the CXCR4 promoter or an increase in 5hmC modification in the CXCR4 gene body. The gene discussed is CXCR4; the disease is colorectal carcinoma.